Phloretin Modulates STING Ubiquitination Degradation to Restrain Dendritic Cell Overactivation and Alleviate Sjögren's Syndrome.

Zhan T, Chen H, Yao J, Yu C

Open source

DOI
10.3390/ph19091398
Published
2026 Sep 4
Container
Pharmaceuticals (Basel, Switzerland)
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/ph19091398,
  title = {Phloretin Modulates STING Ubiquitination Degradation to Restrain Dendritic Cell Overactivation and Alleviate Sjögren's Syndrome.},
  author = {Zhan T and Chen H and Yao J and Yu C},
  year = {2026},
  journal = {Pharmaceuticals (Basel, Switzerland)},
  doi = {10.3390/ph19091398},
  url = {https://doi.org/10.3390/ph19091398}
}

RIS

TY  - JOUR
TI  - Phloretin Modulates STING Ubiquitination Degradation to Restrain Dendritic Cell Overactivation and Alleviate Sjögren's Syndrome.
AU  - Zhan T
AU  - Chen H
AU  - Yao J
AU  - Yu C
PY  - 2026
JO  - Pharmaceuticals (Basel, Switzerland)
DO  - 10.3390/ph19091398
UR  - https://doi.org/10.3390/ph19091398
ER  - 

APA

T, Z., H, C., J, Y., & C, Y. (2026). Phloretin Modulates STING Ubiquitination Degradation to Restrain Dendritic Cell Overactivation and Alleviate Sjögren's Syndrome.. Pharmaceuticals (Basel, Switzerland). https://doi.org/10.3390/ph19091398

Source records